Dexcom and ŌURA have partnered to integrate Dexcom's glucose biosensing feature with the ŌURA Ring's health metrics to help ...

The pharmaceutical giant presented mid-stage trial data on the pill, muvalaplin, at the American Heart Association Scientific ...

It's not always easy to be a long-term investor, particularly when contending with the natural cyclicality that the stock ...

DXCM and smart ring maker, OURA, join forces to help individuals make informed decisions regarding diet, exercise and overall ...

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” third quarter ...

URA recently announced an agreement with Dexcom, and a new report says this focus on blood sugar monitoring could be a “major ...

DexCom invests $75M in Finnish health tech firm ŌURA, forming a strategic partnership to integrate glucose data with vital ...

Oura recently introduced its fourth-generation smart ring, but now it’s focusing on a new partnership with another giant in ...

Smart ring maker Oura announced on Tuesday that it has received a $75 million investment from glucose device maker Dexcom.

Dexcom has invested $75 million into Oura, which values Oura at $5 billion. And the details of the deal could have a ...

Smart ring maker Oura and glucose monitoring giant Dexcom just struck a partnership that will allow the company's products to ...

Dexcom (Nasdaq:DXCM) announced today that it entered into a strategic partnership with Oura, maker of leading smart ring ...